Healios K.K. Income Statement

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	104	560	121	90	41
Revenue Growth (YoY)	-81.43%	362.81%	34.44%	119.51%	51.85%
Cost of Revenue	218	128	13	-	-
Gross Profit	-114	432	108	90	41
Selling, General & Admin	1,265	1,365	1,116	1,378	1,649
Research & Development	2,024	1,960	2,304	3,808	3,700
Other Operating Expenses	-63	-54	1	-10	-2
Operating Expenses	3,226	3,280	3,489	5,247	5,420
Operating Income	-3,340	-2,848	-3,381	-5,157	-5,379
Interest Expense	-200	-87	-146	-418	-583
Interest & Investment Income	1,415	49	19	1	-
Earnings From Equity Investments	-2	-2	2	3	-3
Currency Exchange Gain (Loss)	-	17	74	-21	2
Other Non Operating Income (Expenses)	1	105	298	-29	101
EBT Excluding Unusual Items	-2,126	-2,766	-3,134	-5,621	-5,862
Gain (Loss) on Sale of Investments	-	150	-	-	-10
Asset Writedown	-	-1,446	-492	292	1,411
Pretax Income	-2,126	-4,062	-3,626	-5,329	-4,461
Income Tax Expense	103	165	187	-159	450
Earnings From Continuing Operations	-2,229	-4,227	-3,813	-5,170	-4,911
Minority Interest in Earnings	12	-8	-10	1	1
Net Income	-2,217	-4,235	-3,823	-5,169	-4,910
Net Income to Common	-2,217	-4,235	-3,823	-5,169	-4,910
Shares Outstanding (Basic)	108	88	68	57	53
Shares Outstanding (Diluted)	108	88	68	57	57
Shares Change (YoY)	21.68%	30.10%	19.28%	-0.65%	11.60%
EPS (Basic)	-20.59	-47.87	-56.22	-90.67	-93.36
EPS (Diluted)	-20.59	-47.87	-56.22	-90.67	-99.52
Free Cash Flow	-3,333	-1,832	-2,847	-4,808	-5,382
Free Cash Flow Per Share	-30.96	-20.71	-41.87	-84.34	-93.79
Gross Margin	-109.61%	77.14%	89.26%	100.00%	100.00%
Operating Margin	-3211.54%	-508.57%	-2794.22%	-5730.00%	-13119.51%
Profit Margin	-2131.73%	-756.25%	-3159.50%	-5743.33%	-11975.61%
Free Cash Flow Margin	-3204.81%	-327.14%	-2352.89%	-5342.22%	-13126.83%
EBITDA	-3,065	-2,551	-3,157	-4,771	-5,117
D&A For EBITDA	275	297	224	386	262
EBIT	-3,340	-2,848	-3,381	-5,157	-5,379

Source: S&P Global Market Intelligence. Standard template. Financial Sources.